Hierarchy, tolerance, and dominance in the antitumor T-cell response
- PMID: 11394495
- PMCID: PMC2562287
Hierarchy, tolerance, and dominance in the antitumor T-cell response
Comment on
-
Avoiding tolerance against prostatic antigens with subdominant peptide epitopes.J Immunother. 2001 May-Jun;24(3):237-41. J Immunother. 2001. PMID: 11394501
Similar articles
-
Avoiding tolerance against prostatic antigens with subdominant peptide epitopes.J Immunother. 2001 May-Jun;24(3):237-41. J Immunother. 2001. PMID: 11394501
-
[New immunotherapy for patients with neoplasms using tumor antigens recognized by T lymphocytes].Nihon Naika Gakkai Zasshi. 1998 Dec 10;87(12):2536-44. Nihon Naika Gakkai Zasshi. 1998. PMID: 9922678 Review. Japanese. No abstract available.
-
Cancer immunology: cat and mouse games.Nature. 2005 Sep 1;437(7055):41-2. doi: 10.1038/437041a. Nature. 2005. PMID: 16136120 No abstract available.
-
Clonal deletion of simian virus 40 large T antigen-specific T cells in the transgenic adenocarcinoma of mouse prostate mice: an important role for clonal deletion in shaping the repertoire of T cells specific for antigens overexpressed in solid tumors.J Immunol. 2002 Nov 1;169(9):4761-9. doi: 10.4049/jimmunol.169.9.4761. J Immunol. 2002. PMID: 12391185
-
[Identification of human tumor antigens recognized by T cells].Nihon Rinsho. 2005 Apr;63 Suppl 4:562-7. Nihon Rinsho. 2005. PMID: 15861711 Review. Japanese. No abstract available.
References
-
- Chen W, Anton LC, Bennink JR, et al. Dissecting the multifactorial causes of immunodominance in class I-restricted T cell responses to viruses. Immunity. 2000;1212:83–93. 83–93. - PubMed
-
- Grossmann ME, Davila E, Celis E. Avoiding tolerance against prostatic antigens with subdominant peptide epitopes. J Immunother. 2001;24:237–241. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources